Home > Search Results: rha
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 2 records in 0.03 seconds.
Articles, 2 records found
Articles 2 records found  
1.
7 p, 597.9 KB The IRON Study : Investigation of Robot-assisted Versus Open Nephron-sparing Surgery / Bravi, Carlo Andrea (ORSI Academy (Gant, Bèlgica)) ; Rosiello, Giuseppe (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Mazzone, Elio (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Minervini, Andrea (Careggi Hospital (Florència, Itàlia). Unit of Oncologic Minimally-Invasive Urology and Andrology) ; Mari, Andrea (Careggi Hospital (Florència, Itàlia). Unit of Oncologic Minimally-Invasive Urology and Andrology) ; Di Maida, Fabrizio (Careggi Hospital (Florència, Itàlia). Unit of Oncologic Minimally-Invasive Urology and Andrology) ; Bensalah, Karim (Université de Rennes. Department of Urology) ; Peyronnet, Benoit (Université de Rennes. Department of Urology) ; Khene, Zine-Eddine (Université de Rennes. Department of Urology) ; Schiavina, Riccardo (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Bianchi, Lorenzo (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Mottrie, Alexandre (ORSI Academy, Ghent, Belgium) ; De Naeyer, Geert (Onze Lieve Vrouw Hospital (Aalst, Bèlgica)) ; Antonelli, Alessandro (Azienda Ospedaliera Universitaria Integrata (Verona, Itàlia)) ; Furlan, Maria (Spedali Civili Hospital (Brescia, Itàlia)) ; Rha, Koon Ho (Yonsei University College of Medicine (Seül, Corea)) ; Almujalhem, Ahmad (Yonsei University College of Medicine (Seül, Corea)) ; Derweesh, Ithaar (University of California San Diego School of Medicine) ; Bradshaw, Aaronw (University of California San Diego School of Medicine) ; Kaouk, Jihak (Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA) ; Sawczyn, Guilherme (Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA) ; Bertolo, Riccardo (Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA) ; Breda, Alberto (Institut de Recerca Sant Pau) ; Montorsi, Francesco (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Capitanio, Umberto (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Larcher, Alessandro (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Universitat Autònoma de Barcelona
In this comparative study on robotic versus open partial nephrectomy, functional and oncologic outcomes were similar between the two techniques, with lower morbidity-especially in terms of complications-for robot-assisted surgery. [...]
2023 - 10.1016/j.euros.2022.12.017
European Urology Open Science, Vol. 49 (january 2023) , p. 71-77  
Detailed record - Creative Commons
2.
7 p, 549.5 KB Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma / Powles, Thomas (University of London. Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust, Queen Mary) ; Motzer, Robert J. (Memorial Sloan Kettering Cancer Center) ; Escudier, Bernard (Gustave Roussy) ; Pal, Sumanta (City of Hope National Medical Center) ; Kollmannsberger, Christian (BCCA Vancouver Cancer Centre. British Columbia Cancer Agency) ; Pikiel, Joanna (Wojewodzkie Centrum Onkologii, 80-219 Gdańsk, Poland) ; Gurney, Howard (Macquarie University. Macquarie University and Westmead Hospital) ; Rha, Sun Young (Yonsei Cancer Center. Severance Hospital) ; Park, Se Hoon (Samsung Medical Center) ; Geertsen, Poul F. (Copenhagen University Hospital) ; Gross-Goupil, Marine (Groupe Hospitalier Saint André, 33000 Bordeaux, France) ; Grande, Enrique (Hospital Universitario Ramón y Cajal (Madrid)) ; Suárez, Cristina (Vall d'Hebron Institut d'Oncologia) ; Markby, David W. (Exelixis, Inc) ; Arroyo, Alan (Exelixis, Inc) ; Dean, Mark (Exelixis, Inc) ; Choueiri, Toni K. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; George, Daniel (Duke University Medical Center) ; Universitat Autònoma de Barcelona
In the phase 3 METEOR trial, cabozantinib improved progression-free survival (PFS), objective response rate (ORR), and overall survival (OS) versus everolimus in patients with advanced renal cell carcinoma (RCC), after prior antiangiogenic therapy. [...]
2018 - 10.1038/s41416-018-0164-0
British Journal of Cancer, Vol. 119 (september 2018) , p. 663-669  
Detailed record - Creative Commons

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with